2018 Biosimilars - A Year in Review

The U.S. biologics and biosimilars markets evolved rapidly in 2018. On January 17, life sciences attorneys John Adkisson and Jenny Shmuel will review the U.S. market for biosimilar products and provide insights into:

• Which biosimilars have been approved and launched
• Recent regulatory and legislative actions impacting the biosimilars market
• Select court cases and settlements
• Recent trends in IPR filings in the biosimilars space
• What to look forward to in 2019

The webinar was held on Thursday, January 17, 2019 at 1:00 – 2:00 PM EST.

Fish & Richardson, P.C. is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys that report their required CLE states during their registration process and that log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees that listen to the audio portion only.

This program is designed for and open to all attorneys.

To access a recording of this webinar or receive a copy of the slides, please contact [email protected].